Hoban DJ - Search Results

1

In vitro evaluation of tigecycline and comparative agents in 3049 clinical isolates: 2001 to 2002.

Bouchillon SK, Hoban DJ, Johnson BM, Stevens TM, Dowzicky MJ, Wu DH, Bradford PA. Bouchillon SK, et al. Among authors: hoban dj. Diagn Microbiol Infect Dis. 2005 Apr;51(4):291-5. doi: 10.1016/j.diagmicrobio.2004.11.006. Diagn Microbiol Infect Dis. 2005. PMID: 15808321

2

Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study.

Hoban DJ, Bouchillon SK, Johnson JL, Zhanel GG, Butler DL, Miller LA, Poupard JA; Gemifloxacin Surveillance Study Research Group. Hoban DJ, et al. Diagn Microbiol Infect Dis. 2001 May-Jun;40(1-2):51-7. doi: 10.1016/s0732-8893(01)00241-3. Diagn Microbiol Infect Dis. 2001. PMID: 11448564

3

Comparative in vitro potency of gemifloxacin and fluoroquinolones against recent European clinical isolates from a global surveillance study.

Hoban DJ, Bouchillon SK, Johnson JL, Zhanel GG, Butler DL, Miller LA, Poupard JA; Gemifloxacin Surveillance Study Research Group. Hoban DJ, et al. Eur J Clin Microbiol Infect Dis. 2001 Nov;20(11):814-9. doi: 10.1007/s100960100604. Eur J Clin Microbiol Infect Dis. 2001. PMID: 11783700

4

Comparative in vitro surveillance of amoxicillin-clavulanic acid and four oral comparators against 21232 clinical isolates from europe.

Hoban DJ, Bouchillon SK, Johnson JL, Zhanel GG, Butler DL, Saunders KA, Miller LA, Poupard JA. Hoban DJ, et al. Eur J Clin Microbiol Infect Dis. 2003 Apr;22(4):261-7. doi: 10.1007/s10096-002-0876-0. Epub 2003 Mar 28. Eur J Clin Microbiol Infect Dis. 2003. PMID: 12709842

5

Comparative in vitro potency of amoxycillin-clavulanic acid and four oral agents against recent North American clinical isolates from a global surveillance study.

Hoban DJ, Bouchillon SK, Johnson JL, Zhanel GG, Butler DL, Saunders KA, Miller LA, Poupard JA; Surveillance Study Research Group. Hoban DJ, et al. Int J Antimicrob Agents. 2003 May;21(5):425-33. doi: 10.1016/s0924-8579(03)00038-4. Int J Antimicrob Agents. 2003. PMID: 12727075

6

In vitro activity of gemifloxacin and contemporary oral antimicrobial agents against 27247 Gram-positive and Gram-negative aerobic isolates: a global surveillance study.

Bouchillon SK, Hoban DJ, Johnson JL, Johnson BM, Butler DL, Saunders KA, Miller LA, Poupard JA. Bouchillon SK, et al. Among authors: hoban dj. Int J Antimicrob Agents. 2004 Feb;23(2):181-96. doi: 10.1016/j.ijantimicag.2003.08.006. Int J Antimicrob Agents. 2004. PMID: 15013045

7

Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002.

Bouchillon SK, Johnson BM, Hoban DJ, Johnson JL, Dowzicky MJ, Wu DH, Visalli MA, Bradford PA. Bouchillon SK, et al. Among authors: hoban dj. Int J Antimicrob Agents. 2004 Aug;24(2):119-24. doi: 10.1016/j.ijantimicag.2004.01.010. Int J Antimicrob Agents. 2004. PMID: 15288309

8

In vitro activity of tigecycline against isolates collected from complicated skin and skin structure infections and intra-abdominal infections in Africa and Middle East countries: TEST 2007-2012.

Renteria MI, Biedenbach DJ, Bouchillon SK, Hoban DJ, Raghubir N, Sajben P, Mokaddas E. Renteria MI, et al. Among authors: hoban dj. Diagn Microbiol Infect Dis. 2014 May;79(1):54-9. doi: 10.1016/j.diagmicrobio.2014.01.017. Epub 2014 Jan 30. Diagn Microbiol Infect Dis. 2014. PMID: 24582580

9

Trends in susceptibility of selected gram-negative bacilli isolated from intra-abdominal infections in North America: SMART 2005-2010.

Babinchak T, Badal R, Hoban D, Hackel M, Hawser S, Lob S, Bouchillon S. Babinchak T, et al. Diagn Microbiol Infect Dis. 2013 Jul;76(3):379-81. doi: 10.1016/j.diagmicrobio.2013.02.031. Epub 2013 Mar 27. Diagn Microbiol Infect Dis. 2013. PMID: 23541118

10

In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004).

Bouchillon SK, Hoban DJ, Johnson BM, Johnson JL, Hsiung A, Dowzicky MJ; Tigecycline Evaluation and Surveillance Trial (TEST) Group. Bouchillon SK, et al. Among authors: hoban dj. Diagn Microbiol Infect Dis. 2005 Jul;52(3):173-9. doi: 10.1016/j.diagmicrobio.2005.06.004. Diagn Microbiol Infect Dis. 2005. PMID: 16105561

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

308 results

Search Page